JOHNSON & JOHNSON NEWS
Johnson & Johnson is an international Pharmaceutical, Medical Devices and Consumer Packaged Goods manufacturer founded in 1885. Its common stock is a component of the Dow Jones Industrial Average and listed among the Fortune 500. The corporation's main headquarters is located in New Brunswick, New Jersey. Its consumer division is located in Skillman, New Jersey. The corporation includes some 200 subsidiary companies with operations in over 90 countries, and whose products are sold in over 175. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, and K-Y jelly lubricants.
Alternative To Open Back Surgery - Sponsored Link
Wed, 23 Jul 2008 22:14:00 GMT
Ad - World Leader of Arthroscopic Procedures for Back and Neck Conditions!
[read
more...]
Weak dollar, surge in foreign sales boost second-quarter results as drugmakers beat forecasts
Wed, 23 Jul 2008 22:14:00 GMT
TRENTON, N.J. (AP) _ Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar.U.K.-based
[read
more...]
4 Companies With Strong Cash Flow
Wed, 23 Jul 2008 22:10:00 GMT
EVEN HARDENED WALL Street types can remember the story of the three little pigs. The first little pig built his house with straw, only to see the wolf blow it down. The second pig built his house with sticks and suffered the same fate. The third pig took
[read
more...]
Weak dollar, surge in foreign sales boost second-quarter results as drugmakers beat forecasts
Wed, 23 Jul 2008 22:08:00 GMT
TRENTON, N.J. (AP) _ Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based
[read
more...]
Weak dollar, foreign sales boost drugmakers
Wed, 23 Jul 2008 21:58:00 GMT
TRENTON, N.J. Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies -- nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based GlaxoSmithKline
[read
more...]
Weak dollar, foreign sales boost drugmakers
Wed, 23 Jul 2008 21:18:00 GMT
Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based GlaxoSmithKline PLC, which also
[read
more...]
Weak dollar, foreign sales boost drugmakers
Wed, 23 Jul 2008 20:48:00 GMT
U.K.-based GlaxoSmithKline PLC, which also reported on its second-quarter earnings Wednesday, likewise is targeting emerging markets. Like most of the industry, the companies are trying to stave off growing competition from cheaper generics, which is
[read
more...]
Weak dollar, surge in foreign sales boost second-quarter results as drugmakers beat forecasts
Wed, 23 Jul 2008 20:46:00 GMT
TRENTON, N.J. (AP) - Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based
[read
more...]
Weak dollar, surge in foreign sales boost second - quarter results as drugmakers beat forecasts
Wed, 23 Jul 2008 20:43:00 GMT
TRENTON, N.J. (AP) - Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based
[read
more...]
Weak dollar, foreign sales boost drugmakers
Wed, 23 Jul 2008 20:31:00 GMT
TRENTON, N.J. (AP) -- Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies -- nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. U.K.-based
[read
more...]
Fortune 500 Networking & Best Practice Sharing Conference in Philadelphia: Early Registration Ends This Week
Wed, 23 Jul 2008 20:27:00 GMT
CHAPEL HILL, N.C., July 23 /PRNewswire/ -- Take advantage of quick and easy travel to historic Philadelphia, Pa. to attend the 10th Annual Quality Excellence Conference: How Process Improvement Leaders Produce Profits in Recessions (view full conference
[read
more...]
Publicis N.Y. Names McCarthy CEO
Wed, 23 Jul 2008 19:02:00 GMT
LOS ANGELES Joseph McCarthy is joining Publicis USA in New York as chief executive, replacing Gill Duff, the agency confirmed today. McCarthy joins the shop from Johnson & Johnson, where he was vp, worldwide advertising and marketing communications. He
[read
more...]
Biopharma Firm Earns Pay Day from J&J Subsidiary
Wed, 23 Jul 2008 18:38:00 GMT
Princeton biopharmaceutical company Medarex, Inc. (NASDAQ:MEDX) said today it has received a milestone payment from licensing partner Centocor R&D Inc., a Johnson & Johnson subsidiary. The payment amount was not disclosed. The milestone refers to
[read
more...]
Nielsen warns ad spending may slow this year and next
Wed, 23 Jul 2008 18:28:00 GMT
CORPORATE ad spending will slow down this year and next as advertisers defer their media spending owing to soaring inflation and a weak domestic economy, Nielsen Media Research said Wednesday. Inflation accelerated to a 14-year high of 11.4 percent last
[read
more...]
J&J's McCarthy to Lead Publicis, New York
Wed, 23 Jul 2008 17:26:00 GMT
Succeeds Gill Duff, Who Takes Role With Client Within Holding Company BATAVIA, Ohio (AdAge.com) -- Joe McCarthy, Johnson & Johnson VP-worldwide advertising, is leaving to become CEO of Publicis Worldwide, New York. Joe McCarthy Mr. McCarthy has been a
[read
more...]
Who Really Profits From Smoking Bans?
Wed, 23 Jul 2008 16:26:00 GMT
Opponents of Ohio Bans say 'Just follow the money.' COLUMBUS, Ohio, July 23 COLUMBUS, Ohio, July 23 -- 'Smoking bans in the U.S. have been funded by those who directly profit from the sales of Nicotine Replacement Therapies (NRT),' said Debi Kistner
[read
more...]
Who Really Profits From Smoking Bans?
Wed, 23 Jul 2008 16:24:00 GMT
COLUMBUS, Ohio, July 23 /PRNewswire/ -- 'Smoking bans in the U.S. have been funded by those who directly profit from the sales of Nicotine Replacement Therapies (NRT),' said Debi Kistner with Opponents of Ohio Bans. Robert Wood Johnson, the late CEO of
[read
more...]
Who Really Profits From Smoking Bans?
Wed, 23 Jul 2008 16:20:00 GMT
COLUMBUS, Ohio, July 23 /PRNewswire/ -- 'Smoking bans in the U.S. have been funded by those who directly profit from the sales of Nicotine Replacement Therapies (NRT),' said Debi Kistner with Opponents of Ohio Bans. Robert Wood Johnson, the late CEO of
[read
more...]
Invitation to Q2 2008 Conference Call of MorphoSys AG On July 29, 2008
Wed, 23 Jul 2008 15:21:00 GMT
(PRIME NEWSWIRE) -- MorphoSys AG (FSE:MOR) (Prime Standard Segment, TecDAX) will publish its first six months' 2008 results on July 29, 2008 at 7:30 a.m. CEST.At 10:00 a.m. CEST, the Management Board of MorphoSys AG will host a public conference call to
[read
more...]
Invitation to Q2 2008 Conference Call of MorphoSys AG on July 29, 2008
Wed, 23 Jul 2008 15:10:00 GMT
(GMT+1) MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first six months' 2008 results on July 29, 2008 at 7:30 a.m. CEST. At 10:00 a.m. CEST, the Management Board of MorphoSys AG will host a public conference call to present
[read
more...]
Research and Markets: Medical Equipment Company Share Analysis Report for Johnson & Johnson Vision Care, Inc.
Wed, 23 Jul 2008 13:53:00 GMT
Research and MarketsLaura WoodSenior ManagerFax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716press@researchandmarkets.com
[read
more...]
Research and Markets: Medical Equipment Company Share Analysis Report for Johnson & Johnson Vision Care, Inc.
Wed, 23 Jul 2008 13:34:00 GMT
ET DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dd892f/johnson_johnson) has announced the addition of the 'Johnson & Johnson Vision Care, Inc. Medical Equipment Company Share Analysis' company profile
[read
more...]
Research and Markets: Medical Equipment Company Share Analysis Report for Johnson & Johnson Vision Care, Inc.
Wed, 23 Jul 2008 13:11:00 GMT
(M2 PressWIRE Via Acquire Media NewsEdge) RDATE:23072008 Dublin - Research and Markets (http://www.researchandmarkets.com/research/c94659/johnson_johnson) has announced the addition of the 'Johnson & Johnson Vision Care, Inc. Medical Equipment Company
[read
more...]
Just What the Doctor Ordered: Comparing the Pharma ETFs
Wed, 23 Jul 2008 12:18:00 GMT
click to enlarge The top four holdings in the Pharma HOLDRs (PPH) account for over 60% of the 21 components and include Johnson & Johnson (JNJ 25.8%), Pfizer (PFE 15.6%), Abbott Labs (ABT 11.8%), and Merck (MRK 10%). However, this is by far the most
[read
more...]
New Glaxo chief wants broader, lower-cost company
Wed, 23 Jul 2008 11:37:00 GMT
LONDON (Reuters) - GlaxoSmithKline's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs. Laying out his strategy formally for the first time on
[read
more...]
Insights into "lean healthcare"
Wed, 23 Jul 2008 11:31:00 GMT
New book shares author's experiences Mark Graban shares his years of experience implementing lean principles in various manufacturing industries and translating them in healthcare settings in a new book entitled Lean Hospitals: Improving Quality,
[read
more...]
New Glaxo CEO wants broader, lower-cost company
Wed, 23 Jul 2008 11:08:00 GMT
LONDON, July 23 (Reuters) - GlaxoSmithKline Plc's new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs. Laying out his strategy formally
[read
more...]
New Glaxo CEO wants broader, lower-cost company
Wed, 23 Jul 2008 11:08:00 GMT
LONDON, July 23 (Reuters) - GlaxoSmithKline Plc's (GSK.L: Quote, Profile, Research) new chief executive plans to make the world's second largest drugmaker a broader business and give it a simplified structure, which will reduce its running costs. Laying
[read
more...]
Research and Markets: Medical Equipment Company Share Analysis Report for Johnson & Johnson Vision Care, Inc.
Wed, 23 Jul 2008 10:41:00 GMT
Dublin - Research and Markets (http://www.researchandmarkets.com/research/c94659/johnson-johnson) has announced the addition of the ' Vision Care, Inc. Medical Equipment Company Share Analysis' company profile to their offering. Summary This report is
[read
more...]
Three Stocks To Be Held To Infinity and Beyond
Tue, 22 Jul 2008 23:55:00 GMT
You may think your greatest wealth building asset is the Chevron (CVX) stock you purchased 3 years ago. Even though your brilliant purchase has appreciated over 50% in the last 3 years in the face of a bear market, it is not your greatest wealth building
[read
more...]
powered by zFeeder
Blogos.net